Kura Oncology Inc. (NASDAQ:KURA)’s share price was up 2.4% on Tuesday . The company traded as high as $5.24 and last traded at $5.20, with a volume of 57,165 shares traded. The stock had previously closed at $5.08.

A number of equities analysts recently weighed in on KURA shares. Zacks Investment Research lowered shares of Kura Oncology from a “buy” rating to a “hold” rating in a report on Tuesday, May 17th. Oppenheimer Holdings Inc. restated an “outperform” rating and issued a $16.00 price objective on shares of Kura Oncology in a report on Tuesday, June 21st.

The firm’s 50 day moving average price is $4.33 and its 200 day moving average price is $3.68. The company’s market capitalization is $98.03 million.

Kura Oncology (NASDAQ:KURA) last issued its earnings results on Wednesday, August 10th. The company reported ($0.36) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.34) by $0.02. Equities research analysts predict that Kura Oncology Inc. will post ($1.58) earnings per share for the current year.

Kura Oncology, Inc is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing personalized therapeutics for the treatment of solid tumors and blood cancers. Its segment is engaged in the discovery and development of personalized therapeutics for the treatment of solid tumors and blood cancers.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.